摘要:
A dihydroxy compound characterized by the formula: Wherein R1 and R2 are independently selected from hydrogen and straight and branched alkyl groups containing up to 18 carbon atoms; R3 is selected from —CH═CH— and (—CH2—)k, wherein k is between 0 and 6, inclusive; each Z is independently bromine or iodine, d and n are independently 0, 1 or 2; and X is hydrogen or a pendant group having the structure: wherein Y is selected from straight and branched alkyl and alkyl and alkylaryl groups containing up to 18 carbon atoms.
摘要:
Random block copolymers having the formula: ##STR1## wherein R.sub.1 is --CH.dbd.CH-- or (--CH.sub.2 --).sub.j, in which j is zero or an integer from one to eight; R.sub.2 is selected from hydrogen, straight and branched alkyl and alkylaryl groups containing up to 18 carbon atoms and derivatives or biologically and pharmaceutically active compounds covalently bonded to said copolymer; each R.sub.3 is independently an alkylene group containing up to 4 carbon atoms; y is an integer between about 5 and about 3000; and f is the percent molar fraction of alkylene oxide in the copolymer and ranges between about 1 and about 99 mole percent. Implantable medical devices and drug delivery implants containing the random block copolymers are also disclosed, along with methods for drug delivery and for preventing the formation of adhesions between injured tissues employing the random block copolymers. Polyarylate random block copolymers are also described.
摘要:
Poly(N-phenyl urethanes) and methods of preparing same by heating poly(N-phenyl iminocarbonates) to a temperature above 250.degree. C. so that the backbone of the polyiminocarbonate rearranges to form the poly(N-phenyl urethane). Poly(N-substituted iminocarbonates and methods of preparing same by suspending a dialkaline diphenol in an aprotic solvent at a basic pH and adding to the suspension an N-substituted iminophosgene. Methods for making heat-stable articles by forming an article from a poly(N-phenyl iminocarbonate) while heating the article to a temperature above about 250.degree. C. so that the poly(N-phenyl iminocarbonate) rearranges to form a poly(N-phenyl urethane).
摘要:
Poly(N-phenyl urethanes) and methods of preparing same by heating poly(N-phenyl iminocarbonates) to a temperature above 250.degree. C. so that the backbone of the polyiminocarbonate rearranges to form the poly(N-phenyl urethane). Poly(N-substituted iminocarbonates and methods of preparing same by suspending a dialkaline diphenol in an aprotic solvent at a basic pH and adding to the suspension an N-substituted iminophosgene. Methods for making heat-stable articles by forming an article from a poly(N-phenyl iminocarbonate) while heating the article to a temperature above about 250.degree. C. so that the poly(N-phenyl iminocarbonate) rearranges to form a poly(N-phenyl urethane).
摘要:
Disclosed are biocompatible, bioresorbable polymers comprising a plurality of monomeric repeating units containing an imine group, wherein the inclusion of said imine group is effective to lower the melt viscosity, the solution viscosity, or both, compared to the same polymer without an imine group.
摘要:
A formulation containing a biologically active compound having a chemical structure with hydrogen bonding sites, a first biocompatible, hydrolytically degrading polycarbonate with hydrogen bonding sites and tyrosine-derived diphenol monomer units, and a second biocompatible hydrolytically degrading polymer that is less hydrophobic than the polycarbonate, wherein the second polymer degrades hydrolytically to form acidic degradation products that promote the release of the active compound. Methods for active compound delivery are also disclosed.
摘要:
Degradable polymeric compositions containing water-insoluble drugs blended with copolymers of biocompatible diphenol compound monomer units with pendant carboxylic acid groups polymerized with biocompatible diphenol compound monomer units with pendant carboxylic acid ester groups and poly(alkylene oxide) blocks, wherein the molar fraction in the copolymer of biocompatible diphenol compound monomer units with pendant carboxylic acid groups and poly(alkylene oxide) blocks relative to the weight percentage of the drug in the composition is effective to provide pseudo-zero order release of the drug from the composition during the sustained-release phase of drug delivery under physiological conditions. Ocular treatment methods and manufacturing methods are also disclosed.
摘要:
Methods for constructing tyrosine-derived biotinylated polymers. Biotinylated polymers and polymer scaffolds constructed with the biotinylated polymers are also disclosed.
摘要:
Degradable polymeric compositions containing water-insoluble drugs blended with copolymers of biocompatible diphenol compound monomer units with pendant carboxylic acid groups polymerized with biocompatible diphenol compound monomer units with pendant carboxylic acid ester groups and poly(alkylene oxide) blocks, wherein the molar fraction in the copolymer of biocompatible diphenol compound monomer units with pendant carboxylic acid groups and poly(alkylene oxide) blocks relative to the weight percentage of the drug in the composition is effective to provide pseudo-zero order release of the drug from the composition during the sustained-release phase of drug delivery under physiological conditions. Ocular treatment methods and manufacturing methods are also disclosed.
摘要:
Degradable polymeric compositions containing water-insoluble drugs blended with copolymers of biocompatible diphenol compound monomer units with pendant carboxylic acid groups polymerized with biocompatible diphenol com-pound monomer units with pendant carboxylic acid ester groups and poly(alkylene oxide) blocks, wherein the molar fraction in the copolymer of biocompatible diphenol compound monomer units with pendant carboxylic acid groups and poly(alkylene oxide) blocks relative to the weight percentage of the drug in the composition is effective to provide pseudo-zero order release of the drug from the composition during the sustained-release phase of drug delivery under physiological conditions. Ocular treatment methods and manufacturing methods are also disclosed.